Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T86462 | Target Info | |||
Target Name | Transthyretin (TTR) | ||||
Synonyms | TBPA; Prealbumin; PALB; ATTR | ||||
Target Type | Successful Target | ||||
Gene Name | TTR | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Levothyroxine | Ligand Info | |||
Canonical SMILES | C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N | ||||
InChI | 1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1 | ||||
InChIKey | XUIIKFGFIJCVMT-LBPRGKRZSA-N | ||||
PubChem Compound ID | 5819 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 1ETA THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION | ||||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | Yes | [1] |
PDB Sequence |
GPTGTGESKC
10 PLMVKVLDAV20 RGSPAINVAV30 HVFRKAADDT40 WEPFASGKTS50 ESGELHGLTT 60 EEEFVEGIYK70 VEIDTKSYWK80 ALGISPFHEH90 AEVVFTANDS100 GPRRYTIAAL 110 LSPYSYSTTA120 VVTNPKE
|
|||||
|
||||||
PDB ID: 1ETB THE X-RAY CRYSTAL STRUCTURE REFINEMENTS OF NORMAL HUMAN TRANSTHYRETIN AND THE AMYLOIDOGENIC VAL 30-->MET VARIANT TO 1.7 ANGSTROMS RESOLUTION | ||||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | No | [1] |
PDB Sequence |
KCPLMVKVLD
18 AVRGSPAINV28 AVHVFRKAAD38 DTWEPFASGK48 TSESGELHGL58 TTEEEFVEGI 68 YKVEIDTKSY78 WKALGISPFH88 EHAEVVFTAN98 DSGPRRYTIA108 TLLSPYSYST 118 TAVVTNPK
|
|||||
|
||||||
PDB ID: 3OZK Crystal structure of human transthyretin variant A25T in complex with thyroxine (T4) | ||||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | Yes | [2] |
PDB Sequence |
CPLMVKVLDA
19 VRGSPTINVA29 VHVFRKAADD39 TWEPFASGKT49 SESGELHGLT59 TEEEFVEGIY 69 KVEIDTKSYW79 KALGISPFHE89 HAEVVFTAND99 SGPRRYTIAA109 LLSPYSYSTT 119 AVVTNP
|
|||||
|
||||||
PDB ID: 2ROX TRANSTHYRETIN (ALSO CALLED PREALBUMIN) COMPLEX WITH THYROXINE (T4) | ||||||
Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [3] |
PDB Sequence |
CPLMVKVLDA
19 VRGSPAINVA29 VHVFRKAADD39 TWEPFASGKT49 SESGELHGLT59 TEEEFVEGIY 69 KVEIDTKSYW79 KALGISPFHE89 HAEVVFTAND99 SGPRRYTIAA109 LLSPYSYSTT 119 AVVTNPKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .T44 or .T442 or .T443 or :3T44;style chemicals stick;color identity;select .A:15 or .A:17 or .A:106 or .A:108 or .A:109 or .A:110 or .A:117 or .A:118 or .A:119 or .A:121; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
PDB ID: 5CR1 Crystal structure of TTR/resveratrol/T4 complex | ||||||
Method | X-ray diffraction | Resolution | 1.54 Å | Mutation | Yes | [4] |
PDB Sequence |
CPLMVKVLDA
19 VRGSPAINVA29 VHVFRKAADD39 TWEPFASGKT49 SESGELHGLT59 TEEEFVEGIY 69 KVEIDTKSYW79 KALGSSPFHE89 HAEVVFTAND99 SGPRRYTIAA109 LLSPYSYSTT 119 AVVTNP
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .T44 or .T442 or .T443 or :3T44;style chemicals stick;color identity;select .A:15 or .A:17 or .A:106 or .A:108 or .A:109 or .A:110 or .A:117 or .A:118 or .A:119 or .A:121; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
PDB ID: 1F86 TRANSTHYRETIN THR119MET PROTEIN STABILISATION | ||||||
Method | X-ray diffraction | Resolution | 1.10 Å | Mutation | Yes | [5] |
PDB Sequence |
CPLMVKVLDA
19 VRGSPAINVA29 VHVFRKAADD39 TWEPFASGKT49 SESGELHGLT59 TEEEFVEGIY 69 KVEIDTKSYW79 KALGISPFHE89 HAEVVFTAND99 SGPRRYTIAA109 LLSPYSYSTM 119 AVVTN
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .T44 or .T442 or .T443 or :3T44;style chemicals stick;color identity;select .A:15 or .A:17 or .A:106 or .A:108 or .A:109 or .A:110 or .A:117 or .A:118 or .A:119; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution. J Biol Chem. 1993 Feb 5;268(4):2416-24. | ||||
REF 2 | Crystal structure of human transthyretin variant A25T in complex with thyroxine (T4) | ||||
REF 3 | Structures of human transthyretin complexed with thyroxine at 2.0 A resolution and 3',5'-dinitro-N-acetyl-L-thyronine at 2.2 A resolution. Acta Crystallogr D Biol Crystallogr. 1996 Jul 1;52(Pt 4):758-65. | ||||
REF 4 | Transthyretin Binding Heterogeneity and Anti-amyloidogenic Activity of Natural Polyphenols and Their Metabolites. J Biol Chem. 2015 Dec 11;290(50):29769-80. | ||||
REF 5 | Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution. J Mol Biol. 2001 Mar 2;306(4):733-44. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.